863.7000 18.70 (2.21%)
NSE Aug 29, 2025 15:31 PM
Volume: 260.8K
 

863.70
2.21%
Geojit BNP Paribas
Strides reported its Q2FY22 revenue at Rs. 721cr, (4.8% QoQ, -9% YoY), enabled by a bounce back in the other regulated markets which was partially offset by an underperformance in the US markets. US markets (34% of total revenues) witnessed a 17% QoQ/-38% YoY...
Strides Pharma Science Ltd. is trading above its 200 day SMA of 799.9
More from Strides Pharma Science Ltd.
Recommended